Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02137837 |
| Title | S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Southwest Oncology Group |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |